Sales rise 21.47% to Rs 143.41 crore
Net profit of Caplin Point Laboratories rose 5.91% to Rs 35.29 crore in the quarter ended March 2018 as against Rs 33.32 crore during the previous quarter ended March 2017. Sales rose 21.47% to Rs 143.41 crore in the quarter ended March 2018 as against Rs 118.06 crore during the previous quarter ended March 2017.For the full year,net profit rose 51.46% to Rs 144.64 crore in the year ended March 2018 as against Rs 95.50 crore during the previous year ended March 2017. Sales rose 34.41% to Rs 539.84 crore in the year ended March 2018 as against Rs 401.65 crore during the previous year ended March 2017. ParticularsQuarter EndedYear EndedMar. 2018Mar. 2017% Var.Mar. 2018Mar. 2017% Var.Sales143.41118.06 21 539.84401.65 34 OPM %33.9736.61 -36.0830.97 - PBDT51.6047.58 8 207.37134.25 54 PBT45.4342.59 7 188.38120.95 56 NP35.2933.32 6 144.6495.50 51
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)